Inlyta Cross Word

12345678910111213
Across
  1. 2. Receptor predominantly more responsible for angiogenesis(4)
  2. 5. Inlyta is a ______ coated tablet(4)
  3. 6. The author of the Outcome study of Axitinib Vs Sorafenib to access quality of life(5)
  4. 8. Category 1 recommendation guideline for Inlyta in 2nd line mRCC treatment(4)
  5. 10. Most common side effect of Inlyta(12)
  6. 11. Median PFS of Inlyta in Asian patients (In numeric)(3)
  7. 12. Maximum dose of Inlyta in mg(3)
  8. 13. % Bioavailability of Inlyta (In numeric)(2)
Down
  1. 1. Shelf life of Inlyta in Years(5)
  2. 3. Recommended starting dose of Inlyta in mg BID(5)
  3. 4. % ORR of INLYTA in AXIS 1032 trial (In words)(7)
  4. 5. Metabolites of Axitininb are primarily excreted in(5)
  5. 7. Axitinib is primarily metabolised by organ(5)
  6. 9. Primary enzyme responsile to metabolise Axitinib(8)